{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:38Z","timestamp":1793600798735,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.exer.2026.110953","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T15:58:44Z","timestamp":1772294324000},"page":"110953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["S-methylisothiourea, an iNOS inhibitor, attenuates inflammation in thyroid eye disease-derived orbital fibroblasts by suppressing the iNOS\/NO\/NF-\u03baB signaling pathway"],"prefix":"10.1016","volume":"267","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.exer.2026.110953_bib1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves' disease: a 2014 update","volume":"37","author":"Bartalena","year":"2014","journal-title":"J. Endocrinol. Investig."},{"issue":"5","key":"10.1016\/j.exer.2026.110953_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/joim.13524","article-title":"Current concepts regarding Graves' orbitopathy","volume":"292","author":"Bartalena","year":"2022","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.exer.2026.110953_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.it.2015.01.003","article-title":"Nitric oxide synthase in innate and adaptive immunity: an update","volume":"36","author":"Bogdan","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.exer.2026.110953_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2014.00038","article-title":"Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma","volume":"7","author":"Buys","year":"2014","journal-title":"Front. Mol. Neurosci."},{"issue":"45","key":"10.1016\/j.exer.2026.110953_bib5","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","volume":"273","author":"Cao","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jc.2006-1824","article-title":"Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link","volume":"92","author":"Cawood","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2010.03.001","article-title":"NO synthase: structures and mechanisms","volume":"23","author":"Daff","year":"2010","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"10.1016\/j.exer.2026.110953_bib10","first-page":"1458","article-title":"Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy","volume":"11","author":"Ding","year":"2018","journal-title":"Int. J. Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2026.110953_bib11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/21645515.2016.1276682","article-title":"Targeting iNOS to increase efficacy of immunotherapies","volume":"13","author":"Ekmekcioglu","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.exer.2026.110953_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.648732","article-title":"Mechanisms that underly T cell immunity in graves' orbitopathy","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.exer.2026.110953_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107781","article-title":"Inducible nitric oxide synthase (iNOS): more than an inducible enzyme? Rethinking the classification of NOS isoforms","volume":"216","author":"Farahani","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.exer.2026.110953_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.survophthal.2021.08.010","article-title":"Thinking inside the box: current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease","volume":"67","author":"Gupta","year":"2022","journal-title":"Surv. Ophthalmol."},{"issue":"23","key":"10.1016\/j.exer.2026.110953_bib15","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.3390\/molecules26237306","article-title":"The application of nitric oxide for ocular hypertension treatment","volume":"26","author":"Han","year":"2021","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.exer.2026.110953_bib16","first-page":"1194","article-title":"Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy","volume":"85","author":"Hiromatsu","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","article-title":"Update on clinical management of graves disease and thyroid eye disease","volume":"51","author":"Hoang","year":"2022","journal-title":"Endocrinol Metab. Clin. N. Am."},{"key":"10.1016\/j.exer.2026.110953_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108280","article-title":"Prolonged use of nitric oxide donor sodium nitroprusside induces ocular hypertension in mice","volume":"202","author":"Hu","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10753-021-01593-x","article-title":"Amelioration of neuropathic pain and attenuation of neuroinflammation responses by tetrahydropalmatine through the p38MAPK\/NF-\u03baB\/iNOS signaling pathways in animal and cellular models","volume":"45","author":"Hu","year":"2022","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br. J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2026.110953_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/iovs.62.9.24","article-title":"Transcriptomic profiling of control and thyroid-Thyroid-Associated Orbitopathy (TAO) orbital fat and TAO orbital fibroblasts undergoing adipogenesis","volume":"62","author":"Kim","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib22","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaf009","article-title":"Mechanisms in thyroid eye disease: the TSH receptor interacts directly with the IGF-1 receptor","volume":"166","author":"Latif","year":"2025","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148645","article-title":"The effect of (-)-Epigallocatechin-3-Gallate on IL-1\u03b2 induced IL-8 expression in orbital fibroblast from patients with thyroid-associated ophthalmopathy","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.exer.2026.110953_bib24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1167\/iovs.61.5.64","article-title":"Gypenosides protect orbital fibroblasts in graves ophthalmopathy via anti-inflammation and anti-fibrosis effects","volume":"61","author":"Li","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2026.110953_bib25","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00018-011-0760-0","article-title":"The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics","volume":"69","author":"Lie","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.exer.2026.110953_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00129784-200303050-00002","article-title":"Clinical potential of advanced glycation end-product inhibitors in diabetes mellitus","volume":"3","author":"Men\u00e8","year":"2003","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"3","key":"10.1016\/j.exer.2026.110953_bib27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/med.21636","article-title":"Inducible nitric oxide synthase inhibitors: a comprehensive update","volume":"40","author":"Minhas","year":"2020","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.exer.2026.110953_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/aos.13384","article-title":"Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches","volume":"96","author":"Opatrilova","year":"2018","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.exer.2026.110953_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"issue":"13","key":"10.1016\/j.exer.2026.110953_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.65.13.13","article-title":"Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts","volume":"65","author":"Papp","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2026.110953_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/412158","article-title":"Markers of inflammation and fibrosis in the orbital fat\/connective tissue of patients with Graves' orbitopathy: clinical implications","volume":"2014","author":"Pawlowski","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"11","key":"10.1016\/j.exer.2026.110953_bib32","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.freeradbiomed.2011.08.034","article-title":"Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase","volume":"51","author":"Robinson","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.exer.2026.110953_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.12659\/MSM.891177","article-title":"Inducible and endothelial nitric synthetase expression and nitrotyrosine accumulation in Iris vasculature of patients with primary open-angle glaucoma: a pilot study","volume":"21","author":"Rokicki","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"4","key":"10.1016\/j.exer.2026.110953_bib34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1530\/EJE-16-0945","article-title":"Distinct inflammatory gene expression in extraocular muscle and fat from patients with Graves' orbitopathy","volume":"176","author":"Romero-Kusabara","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"10.1016\/j.exer.2026.110953_bib35","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1167\/iovs.13-13762","article-title":"S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy","volume":"55","author":"Rosales","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2026.110953_bib36","doi-asserted-by":"crossref","first-page":"e3125","DOI":"10.1210\/clinem\/dgab154","article-title":"IL-38 exerts anti-inflammatory and antifibrotic effects in thyroid-associated ophthalmopathy","volume":"106","author":"Shi","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2026.110953_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111097","article-title":"iNOS inhibitor S-methylisothiourea alleviates smoke inhalation-induced acute lung injury by suppressing inflammation and macrophage infiltration","volume":"126","author":"Shi","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"Suppl. l_1","key":"10.1016\/j.exer.2026.110953_bib38","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1210\/clinem\/dgac328","article-title":"Understanding pathogenesis intersects with effective treatment for thyroid eye disease","volume":"107","author":"Smith","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.exer.2026.110953_bib39","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1476-5381.1995.tb13256.x","article-title":"Isothioureas: potent inhibitors of nitric oxide synthases with variable isoform selectivity","volume":"114","author":"Southan","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.exer.2026.110953_bib41","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1073\/pnas.88.17.7773","article-title":"Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein","volume":"88","author":"Stuehr","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"26","key":"10.1016\/j.exer.2026.110953_bib42","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1073\/pnas.91.26.12472","article-title":"Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase","volume":"91","author":"Szab\u00f3","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.exer.2026.110953_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1167\/iovs.61.8.17","article-title":"Retinoic acid potentiates orbital tissues for inflammation through NF-\u03baB and MCP-1","volume":"61","author":"Unsworth","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2026.110953_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056349","article-title":"SKLB023 blocks joint inflammation and cartilage destruction in arthritis models via suppression of nuclear factor-kappa B activation in macrophage","volume":"8","author":"Xie","year":"2013","journal-title":"PLoS One"},{"issue":"54","key":"10.1016\/j.exer.2026.110953_bib45","doi-asserted-by":"crossref","first-page":"30919","DOI":"10.1039\/C8RA04955F","article-title":"SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta\/Smad signaling pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"RSC Adv."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483526001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:32:28Z","timestamp":1793597548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483526001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"alternative-id":["S0014483526001090"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2026.110953","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S-methylisothiourea, an iNOS inhibitor, attenuates inflammation in thyroid eye disease-derived orbital fibroblasts by suppressing the iNOS\/NO\/NF-\u03baB signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2026.110953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110953"}}